Befotertinib

· Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Befotertinib, covering 2023-09-22 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy [Phase 2]